This analysis reveals PIGT role in HCC tumor progression and identifies HOXB7 as a vital regulator, suggesting therapeutic targets.
Glycosylphosphatidylinositol-anchored proteins (GPI-APs) contribute to cancer progression, with their glycolipid modification mediated by glycosylphosphatidylinositol transamidase (GPIT). Phosphatidylinositol glycan anchor biosynthesis class T (PIGT), a key GPIT subunit, influences GPI-APs biosynthesis and tumor biology. This study investigates PIGT expression in hepatocellular carcinoma (HCC) and its regulatory mechanisms. HCC genome sequencing and The Cancer Genome Atlas (TCGA) database were analyzed to compare PIGT expression between tumor and adjacent normal tissues. PIGT knockdown and overexpression cell lines examined its influence on HCC cell proliferation, migration, and invasion. Gene Set Enrichment Analysis (GSEA) identified downstream pathways, and Japan Australia Singapore Profiling Array Repository (JASPAR) predicted upstream transcriptional regulators, which were validated by in vivo tumor models. PIGT was upregulated in HCC, enhancing tumor cell aggressiveness. GSEA implicated oncogenic pathways, and JASPAR identified homeobox B7 (HOXB7) as key transcriptional regulator. Animal models validated HOXB7-induced PIGT upregulation and its role in HCC progression. PIGT promotes HCC malignancy via the Wnt/β-catenin pathway, with HOXB7 as its upstream regulator.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: